Send feedback

CNN3

gene
On this page

Summary

CNN3 (calponin 3, HGNC:2157) is a protein-coding gene on chromosome 1p21.3, encoding Calponin-3 (Q15417). Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction.

This gene encodes a protein with a markedly acidic C terminus; the basic N-terminus is highly homologous to the N-terminus of a related gene, CNN1. Members of the CNN gene family all contain similar tandemly repeated motifs. This encoded protein is associated with the cytoskeleton but is not involved in contraction.

Source: NCBI Gene 1266 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 33 total — 1 pathogenic
  • GTEx eGene: eQTL in 26 tissues, sQTL in 4 (q < 0.05)
  • Constraint (gnomAD): pLI 1.00 (loss-of-function intolerant), LOEUF 0.43 (moderately constrained)
  • MANE Select transcript: NM_001839
  • Interaction hub: 1,725 STRING partners (top 10% of genes corpus-wide)

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:2157
Approved symbolCNN3
Namecalponin 3
Location1p21.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000117519
Ensembl biotypeprotein_coding
OMIM602374
Entrez1266

Gene structure

Transcript identifiers

Ensembl transcripts: 18 — 12 protein_coding, 3 protein_coding_CDS_not_defined, 3 nonsense_mediated_decay

MANE Select: ENST00000370206

Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 5, TSL 3: 1

ENST00000370206, ENST00000394202, ENST00000415017, ENST00000461018, ENST00000474409, ENST00000487539, ENST00000545882, ENST00000885995, ENST00000885996, ENST00000939684, ENST00000939685, ENST00000998672, ENST00001022727, ENST00001022733, ENST00001121661, ENST00001123633, ENST00001123634, ENST00001144648

RefSeq mRNA: 3 — MANE Select: NM_001839 NM_001286055, NM_001286056, NM_001839

CCDS: CCDS30775, CCDS65592, CCDS65593

Canonical transcript exons

ENST00000370206 — 7 exons

ExonStartEnd
ENSE000018875369489695794898083
ENSE000019280469492683894927110
ENSE000034771549489937194899517
ENSE000035232789490212194902258
ENSE000035271459490166994901785
ENSE000036435949490312294903188
ENSE000036617699490340394903524

Expression profiles

Bgee: expression breadth ubiquitous, 289 present calls, max score 99.68.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 238.6389 / max 1615.8375, expressed in 1474 samples.

Highest expression (Bgee): ventricular zone, calcaneal tendon, ganglionic eminence, adrenal gland, tibial nerve.

Genetic regulation across tissues (GTEx eQTL / sQTL)

CNN3 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 26 tissues and its splicing (sQTL) in 4 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.

showing 20 of 30 significant tissue × QTL associations:

TissueQTLq-valueSlopeLead variant
Brain Cerebellar Hemisphereeqtl9.6e-30+0.711:94855162:T:C
Brain Cerebellumeqtl1.6e-19+0.481:94855162:T:C
Nerve Tibialeqtl3.1e-09-0.151:94909143:T:C
Esophagus Musculariseqtl6.7e-09-0.201:94899861:A:G
Colon Sigmoideqtl7.6e-07+0.151:94887366:ATC:A
Artery Aortaeqtl2.4e-06-0.191:94919559:C:G
Adipose Subcutaneouseqtl7.8e-06+0.131:94892540:A:G
Brain Caudate basal gangliaeqtl2.5e-05+0.131:94887607:A:G
Colon Transverseeqtl5.6e-05-0.121:94960809:A:G
Skin Sun Exposed Lower legeqtl1.2e-04+0.161:95142839:G:C
Artery Coronaryeqtl1.6e-04-0.261:94899861:A:G
Esophagus Gastroesophageal Junctioneqtl1.8e-04-0.171:94899861:A:G
Skin Not Sun Exposed Suprapubiceqtl2.4e-04+0.091:94945045:C:A
Artery Tibialeqtl2.6e-04+0.101:94887145:T:A
Breast Mammary Tissueeqtl4.0e-04+0.131:94906171:C:T
Brain Cortexeqtl7.0e-04+0.111:94887607:A:G
Brain Nucleus accumbens basal gangliaeqtl8.8e-04+0.131:94887607:A:G
Brain Frontal Cortex BA9eqtl1.0e-03+0.111:94887607:A:G
Heart Left Ventricleeqtl1.4e-03+0.181:94932483:G:T
Cells Cultured fibroblastseqtl1.5e-03+0.121:94887650:G:T

FANTOM5 promoters

5 alternative TSS:

Promoter IDTPM avgSamples expressed
13424221.48531469
1342315.89351343
134220.9221347
134210.220387
134250.117828

Top tissues by expression

showing 100 of 295 tissues by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ventricular zoneUBERON:000305399.68gold quality
calcaneal tendonUBERON:000370199.50gold quality
ganglionic eminenceUBERON:000402399.39gold quality
left adrenal glandUBERON:000123499.28gold quality
right adrenal glandUBERON:000123399.26gold quality
tibial nerveUBERON:000132399.25gold quality
body of uterusUBERON:000985399.23gold quality
left adrenal gland cortexUBERON:003582599.22gold quality
right adrenal gland cortexUBERON:003582799.19gold quality
left uterine tubeUBERON:000130399.12gold quality
right lungUBERON:000216799.07gold quality
metanephros cortexUBERON:001053399.07gold quality
ectocervixUBERON:001224999.03gold quality
adrenal glandUBERON:000236999.01gold quality
colonic epitheliumUBERON:000039799.00gold quality
adrenal tissueUBERON:001830399.00gold quality
upper lobe of left lungUBERON:000895298.98gold quality
gall bladderUBERON:000211098.94gold quality
right coronary arteryUBERON:000162598.93gold quality
left ovaryUBERON:000211998.93gold quality
left coronary arteryUBERON:000162698.91gold quality
right ovaryUBERON:000211898.88gold quality
stromal cell of endometriumCL:000225598.87gold quality
oocyteCL:000002398.86gold quality
adrenal cortexUBERON:000123598.78gold quality
ascending aortaUBERON:000149698.77gold quality
thoracic aortaUBERON:000151598.77gold quality
upper lobe of lungUBERON:000894898.76gold quality
left lobe of thyroid glandUBERON:000112098.72gold quality
olfactory segment of nasal mucosaUBERON:000538698.67gold quality
endocervixUBERON:000045898.65gold quality
aortaUBERON:000094798.65gold quality
omental fat padUBERON:001041498.63gold quality
peritoneumUBERON:000235898.62gold quality
tibial arteryUBERON:000761098.61gold quality
popliteal arteryUBERON:000225098.60gold quality
descending thoracic aortaUBERON:000234598.58gold quality
right lobe of thyroid glandUBERON:000111998.57gold quality
pericardiumUBERON:000240798.55gold quality
lower esophagusUBERON:001347398.54gold quality
muscle layer of sigmoid colonUBERON:003580598.54gold quality
lower esophagus muscularis layerUBERON:003583398.54gold quality
esophagogastric junction muscularis propriaUBERON:003584198.53gold quality
minor salivary glandUBERON:000183098.44gold quality
lower esophagus mucosaUBERON:003583498.36gold quality
adenohypophysisUBERON:000219698.32gold quality
embryoUBERON:000092298.31gold quality
adipose tissue of abdominal regionUBERON:000780898.29gold quality
esophagusUBERON:000104398.28gold quality
secondary oocyteCL:000065598.18gold quality
mucosa of stomachUBERON:000119998.17gold quality
coronary arteryUBERON:000162198.09gold quality
esophagus mucosaUBERON:000246998.06gold quality
right atrium auricular regionUBERON:000663197.94gold quality
C1 segment of cervical spinal cordUBERON:000646997.78gold quality
subcutaneous adipose tissueUBERON:000219097.77gold quality
rectumUBERON:000105297.74gold quality
thyroid glandUBERON:000204697.71gold quality
amygdalaUBERON:000187697.67gold quality
seminal vesicleUBERON:000099897.64gold quality
spinal cordUBERON:000224097.55gold quality
body of stomachUBERON:000116197.53gold quality
transverse colonUBERON:000115797.49gold quality
sigmoid colonUBERON:000115997.47gold quality
cortical plateUBERON:000534397.39gold quality
caudate nucleusUBERON:000187397.33gold quality
cardiac atriumUBERON:000208197.31gold quality
small intestine Peyer’s patchUBERON:000345497.27gold quality
adipose tissueUBERON:000101397.19gold quality
islet of LangerhansUBERON:000000697.11gold quality
nucleus accumbensUBERON:000188297.08gold quality
body of pancreasUBERON:000115097.07gold quality
adult mammalian kidneyUBERON:000008297.04gold quality
small intestineUBERON:000210897.04gold quality
smooth muscle tissueUBERON:000113597.00gold quality
right frontal lobeUBERON:000281097.00gold quality
myometriumUBERON:000129696.96gold quality
hypothalamusUBERON:000189896.96gold quality
right uterine tubeUBERON:000130296.92gold quality
anterior cingulate cortexUBERON:000983596.83gold quality
duodenumUBERON:000211496.82gold quality
cingulate cortexUBERON:000302796.82gold quality
colonUBERON:000115596.80gold quality
stomachUBERON:000094596.75gold quality
cartilage tissueUBERON:000241896.73gold quality
putamenUBERON:000187496.68gold quality
vena cavaUBERON:000408796.65gold quality
cauda epididymisUBERON:000436096.65gold quality
pituitary glandUBERON:000000796.64gold quality
intestineUBERON:000016096.64gold quality
connective tissueUBERON:000238496.54gold quality
saliva-secreting glandUBERON:000104496.51gold quality
pancreasUBERON:000126496.46gold quality
large intestineUBERON:000005996.45gold quality
right lobe of liverUBERON:000111496.45gold quality
lungUBERON:000204896.45gold quality
skin of legUBERON:000151196.41gold quality
mouth mucosaUBERON:000372996.40gold quality
corpus callosumUBERON:000233696.35gold quality
mucosa of transverse colonUBERON:000499196.30gold quality

Single-cell (SCXA)

Detected in 35 experiment(s), a significant marker in 30.

ExperimentMarker?Max mean expression
E-GEOD-180759yes1749.93
E-GEOD-84465yes1516.07
E-MTAB-9154yes1367.08
E-MTAB-8142yes1333.38
E-MTAB-9435yes1308.70
E-MTAB-11121yes1000.38
E-HCAD-10yes907.43
E-HCAD-1yes78.42
E-MTAB-6701yes64.60
E-MTAB-8410yes56.77
E-MTAB-10553yes51.91
E-HCAD-5yes37.25
E-HCAD-11yes35.91
E-MTAB-7316yes33.09
E-GEOD-137537yes32.32

HPA expression

RNA tissue specificity: Low tissue specificity

showing 60 of 78 HPA tissues / cells by nTPM:

Tissue / cellAxisnTPMProtein (IHC)
Spinal cordtissue407.8
Medulla oblongatatissue294.9
Corpus callosumtissue291.8
Midbraintissue290.0
Substantia nigratissue286.2
Olfactory bulbtissue283.9
Periaqueductal graytissue268.4
Placentatissue240.5medium
Hypothalamustissue230.7
Thalamustissue229.7
Ponstissue227.0
Hippocampal formationtissue225.4
Superior colliculitissue213.1
Adrenal glandtissue202.8medium
Amygdalatissue192.1
Endometrium 1tissue191.9medium
Septumtissue184.1
Smooth muscletissue183.0medium
Kidneytissue180.9medium
Vaginatissue175.3low
Ventral forebraintissue158.6
Basal gangliatissue158.3medium
Putamentissue154.3
Ovarytissue152.6medium
Urinary bladdertissue146.1medium
Hippocampustissue145.1medium
Gallbladdertissue142.7medium
Entorhinal cortextissue142.4
Cerebral cortextissue140.7medium
Motor cortextissue140.7
Esophagustissue140.6low
Temporal cortextissue138.8
Adipose tissuetissue138.7not detected
Choroid plexustissue138.3
Livertissue134.4low
Cervixtissue134.2low
Prefrontal cortextissue132.8
Retrosplenial cortextissue132.2
Insular cortextissue128.2
Duodenumtissue127.9high
Seminal vesicletissue125.9medium
Occipital cortextissue124.3
Somatosensory cortextissue120.8
Nucleus accumbenstissue119.2
Retrosplenial and cingulate cortextissue117.7
Retinatissue115.9
Locus coeruleustissue114.5
Lungtissue111.6medium
Postcentral gyrustissue110.7
Pituitary glandtissue105.8
Breasttissue99.8medium
Prostatetissue98.0medium
Small intestinetissue94.2high
Cerebellumtissue90.3medium
Spleentissue88.6low
Caudate putamentissue87.3
Heart muscletissue83.9low
Fallopian tubetissue83.0medium
Thyroid glandtissue82.4medium
Pancreastissue78.6low

Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Ventral spinal cord (407.8), Dorsal spinal cord (379.8), White matter (291.8), Area postrema (246.0), Supraoptic nucleus (231.0).

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

Targeting CNN3 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).

showing 30 of 64 miRNAs:

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-548N99.9871.944170
HSA-MIR-548P99.9872.253784
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-548AN99.9770.912817
HSA-MIR-96-5P99.9572.802140
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-651-3P99.9473.485177
HSA-MIR-1-3P99.9372.351914
HSA-MIR-20699.9372.501893
HSA-MIR-1213399.9271.822006
HSA-MIR-61399.9171.501710
HSA-MIR-1271-5P99.9171.991972
HSA-MIR-124-3P99.8973.743043
HSA-MIR-506-3P99.8973.553057
HSA-MIR-129-5P99.8870.263273
HSA-MIR-383-3P99.8565.841359
HSA-MIR-449599.8272.083080
HSA-MIR-202-5P99.7867.65991
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-471999.7372.103329
HSA-MIR-425599.7267.701541
HSA-MIR-7-5P99.6770.531809
HSA-MIR-570099.6469.882280

Functional genomics

gnomAD constraint: pLI 0.999, LOEUF 0.43, missense Z 2.77 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD

Regional missense constraint (gnomAD RMC): no regional variation along ENST00000370206 — one region, missense o/e 0.66.

Literature-anchored findings (GeneRIF, showing 12)

  • These results suggest a role of calponin 3 in the regulation of Bone morphogenetic proteins -dependent cellular responses. (PMID:17825283)
  • Gene rearrangements of CNN3 is associated with mucosa-associated lymphoid tissue lymphoma. (PMID:18927281)
  • Results indicate that CNN3 regulates actin cytoskeleton rearrangement which is required for the plasma membranes of trophoblasts to become fusion competent. (PMID:20861310)
  • The mRNA and protein level of calponin-3 were increase expression in brain in patiens with epilepsy. (PMID:22119193)
  • Participates in actin stress fiber remodeling (PMID:23545751)
  • CNN3 as a new pro-invasive protein in trophoblast cells that is induced under low oxygen conditions. (PMID:25050546)
  • overexpressed CNN3 during sonic vibration increases expression of glutamate receptors and promotes functional neural differentiation of human umbilical cords-mesenchymal stem cells. (PMID:26175098)
  • These results reveal the importance of the MEKK1-calponin-3 signaling pathway to cell contractility. (PMID:27528401)
  • Cnn3 depletion resulted in increased and uncoordinated contractility of stress fibers that often led to breakage of individual actomyosin bundles within the stress fiber network. (PMID:30518778)
  • CNN3 acts as a potential oncogene in cervical cancer by affecting RPLP1 mRNA expression. (PMID:32051425)
  • Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma. (PMID:32667904)
  • Calponin 3 Acts as a Potential Diagnostic and Prognostic Marker and Promotes Glioma Cell Proliferation, Migration, and Invasion. (PMID:35792226)

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_reriocnn3bENSDARG00000029856
danio_reriocnn3aENSDARG00000099510
mus_musculusCnn3ENSMUSG00000053931
rattus_norvegicusCnn3ENSRNOG00000011559
caenorhabditis_elegansWBGENE00000778
caenorhabditis_eleganscpn-3WBGENE00000779
caenorhabditis_eleganscpn-4WBGENE00000780

Paralogs (5): CNN2 (ENSG00000064666), CNN1 (ENSG00000130176), TAGLN3 (ENSG00000144834), TAGLN (ENSG00000149591), TAGLN2 (ENSG00000158710)

Mouse-model phenotypes

Observed phenotypes of the mouse ortholog (MGI:1919244) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 3 distinct phenotype terms.

Mouse phenotype (MP)Records
exencephaly1
abnormal nervous system development1
neonatal lethality, complete penetrance1

Additional cross-species homologs

Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.

OrganismUniProtIdentityMethod
Macaca fascicularisQ4R5J4100.0%Diamond
Pongo abeliiQ5RFN6100.0%Diamond
Sus scrofaQ0809299.7%Diamond
Bos taurusQ2HJ3899.7%Diamond
Ovis ariesQ7YRL299.7%Diamond
Mustela putorius furoQ9GK3899.0%Diamond
Gallus gallusP2693298.9%Diamond
Meleagris gallopavoP3780398.9%Diamond
Xenopus laevisQ3KQW757.5%Diamond
Drosophila melanogasterP1431851.7%Diamond
Echinococcus granulosusQ2479951.1%Diamond
Dictyostelium discoideumQ55GV947.2%Diamond

Genomic neighbors (locus context)

Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).

SymbolTypeEntrez
SLC44A3-AS1ncRNA101928079
SLC44A3protein-coding126969
CNN3-DTncRNA729970
MIR378GncRNA100616321
MIR12133ncRNA113219466
F3protein-coding2152
TLCD4-RWDD3protein-coding100527978
ALG14-AS1ncRNA101928098
RWDD3-DTncRNA101928118
TLCD4protein-coding148534
ALG14protein-coding199857
RWDD3protein-coding25950

Protein

Protein identifiers

Calponin-3 — Q15417 (reviewed: Q15417)

Alternative names: Calponin, acidic isoform

All UniProt accessions (2): E9PDU6, Q15417

UniProt curated annotations — full annotation on UniProt →

Function. Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity.

Tissue specificity. Expressed in both non-smooth muscle tissues as well as smooth muscle tissues.

Similarity. Belongs to the calponin family.

Isoforms (3)

UniProt IDNamesCanonical?
Q15417-11yes
Q15417-22
Q15417-33

RefSeq proteins (3): NP_001272984, NP_001272985, NP_001830* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000557Calponin_repeatRepeat
IPR001715CH_domDomain
IPR001997Calponin/LIMCH1Family
IPR003096SM22_calponinFamily
IPR036872CH_dom_sfHomologous_superfamily
IPR050606Calponin-likeFamily

Pfam: PF00307, PF00402

UniProt features (13 total): repeat 3, modified residue 3, splice variant 2, chain 1, domain 1, sequence conflict 1, region of interest 1, compositionally biased region 1

Structure

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q15417-F167.780.33

Human Protein Atlas

Protein class: Predicted intracellular proteins, Plasma proteins

Protein evidence: Evidence at protein level

Subcellular location (HPA, imaging): actin filaments; cytosol

Antibody reliability (HPA): IH enhanced · IF enhanced

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3)

TypePositions
N6-acetyllysine23
N6-methyllysine158
Phosphoserine323

Function

Pathways and Gene Ontology

Reactome pathways

0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).

MSigDB gene sets: 332 (showing top): MODULE_52, GOBP_EPITHELIUM_DEVELOPMENT, BOYLAN_MULTIPLE_MYELOMA_PCA1_DN, KAAB_FAILED_HEART_ATRIUM_DN, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, MAZ_Q6, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP, CTATGCA_MIR153, CHX10_01, LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN, GOBP_CELL_CELL_ADHESION, MODULE_118, WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN

GO Biological Process (4): actin filament organization (GO:0007015), epithelial cell differentiation (GO:0030855), actomyosin structure organization (GO:0031032), cell-cell adhesion (GO:0098609)

GO Molecular Function (5): calmodulin binding (GO:0005516), actin filament binding (GO:0051015), cadherin binding involved in cell-cell adhesion (GO:0098641), actin binding (GO:0003779), protein binding (GO:0005515)

GO Cellular Component (4): cytosol (GO:0005829), adherens junction (GO:0005912), focal adhesion (GO:0005925), actin cytoskeleton (GO:0015629)

GO top-level categories

18 GO namespaces:

CategoryTerms
actin cytoskeleton organization2
supramolecular fiber organization1
cell differentiation1
epithelium development1
cell adhesion1
protein binding1
actin binding1
protein-containing complex binding1
cadherin binding1
cell-cell adhesion1
cell-cell adhesion mediator activity1
cytoskeletal protein binding1
binding1
cytoplasm1
cellular anatomical structure1
cell-cell junction1
cell-substrate junction1
cytoskeleton1

Experimentally-supported GO annotations

GO terms backed by direct experimental evidence (ECO experimental codes) — 6 of 13 annotations. The rest are phylogenetic / computational / electronic (IEA).

6 experimentally-supported GO terms:

GO termNSEvidence
epithelial cell differentiationBPexpression pattern
actin cytoskeletonCCdirect assay
adherens junctionCChigh-throughput assay
cytosolCCdirect assay
focal adhesionCChigh-throughput assay
cadherin binding involved in cell-cell adhesionMFhigh-throughput assay

Protein interactions and networks

STRING

showing 17 of 1,725 interactions by confidence (×1000):

Protein AProtein BPartner UniProtScore
CNN3VCLP18206603
CNN3CALML4Q96GE6485
CNN3DSTNP18282473
CNN3CALML3P27482472
CNN3CALML5Q9NZT1472
CNN3CALM1P02593471
CNN3CALD1Q05682447
CNN3PDLIM4P50479446
CNN3CALML6Q8TD86443
CNN3SMTNP53814426
CNN3MYH14Q7Z406410
CNN3TMOD3Q9NYL9390
CNN3DOCK7Q96N67383
CNN3RSPH1Q8WYR4370
CNN3CALB2P22676370
CNN3DSTQ03001370
CNN3MACF1Q9UPN3370

IntAct

Human interaction partners of CNN3 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).

4 partners by confidence:

PartnerInteraction typeMIscoreRecords
CARM1physical association0.4001
CRMP1physical association0.4001
F2RL1physical association0.3701
ATE1association0.3501

BioGRID (111 interactions; top human partners by supporting records): ACTB (Proximity Label-MS; 3 records), CNN2 (Affinity Capture-MS; 3 records), PARK2 (Affinity Capture-MS; 3 records), ACTC1 (Proximity Label-MS; 2 records), CARM1 (Affinity Capture-MS; 2 records), HSPA1A (Affinity Capture-MS; 2 records), KCNA3 (Proximity Label-MS; 2 records), MAPT (Proximity Label-MS; 2 records), PARP1 (Proximity Label-MS; 2 records), SNCA (Proximity Label-MS; 2 records), YAP1 (Proximity Label-MS; 2 records), ACTA1 (Cross-Linking-MS (XL-MS)), ACTA2 (Cross-Linking-MS (XL-MS)), ACTG2 (Cross-Linking-MS (XL-MS)), BAP1 (Affinity Capture-MS)

SIGNOR signaling

2 signaling interactions:

AEffectBMechanism
BTK“up-regulates quantity”CNN3phosphorylation
FYN“down-regulates activity”CNN3phosphorylation

Protein complexes (CORUM) (1)

Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).

1 complexes by size:

ComplexSubunitsMembers
Emerin complex 18ACTB, CNN3, EMD, LMO7, MYH9, MYO1E, SIKE1, SPTAN1

Disease & clinical

Genetic variants

Variant evidence for CNN3: 33 ClinVar records (1 pathogenic / likely pathogenic); 3 GWAS associations. Per-variant detail is on Sugi Variant.

ClinVar

33 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance25
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Showing all 1 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.

Variant IDHGVSClassificationReviewSubmitters
1073069NC_000001.10:g.(?94458793)(95538454_?)delPathogeniccriteria provided, single submitter1

Per-variant reference — Sugi Variant

Explore CNN3’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.

SpliceAI

Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 37 predictions of 533):

Position(s)EffectΔscoreSites
1:94899369–94899370donor_loss1.00005
1:94899519–94899521acceptor_gain1.00002
1:94899526acceptor_gain1.0000
1:94901667–94901668donor_loss1.00005
1:94901786–94901787acceptor_loss1.00006
1:94902119–94902120donor_loss1.00005
1:94902259acceptor_loss1.0000
1:94903120–94903121donor_loss1.00005
1:94903189–94903190acceptor_loss1.00006
1:94903397donor_gain1.0000

AlphaMissense

1,236 missense substitutions predicted likely pathogenic (of 2,188 scored), across 254 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:

ResidueLikely-pathogenic substitutionsMean am_pathogenicityMax am_pathogenicity
M17990.9900.999
M16890.9810.999
M20890.9810.999
M24790.9560.996
M21990.9490.996
M25890.8830.987
D10880.9970.999
F10480.9961.000
N8580.9920.997
N17180.9830.999
F15280.9791.000
F8980.9780.999
D10280.9780.995
D20080.9780.994
N21180.9730.999
N11480.9690.999
F4880.9530.999
D26980.9510.992
D19080.9450.990
F480.9340.996

HPA cancer prognostics

RNA cancer specificity: Cancer enhanced (Glioblastoma Multiforme)

Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.

1 prognostic cancer types:

CancerPrognosticp-value
Kidney Renal Clear Cell Carcinoma (TCGA)favorable1.94e-08

Disease associations

OMIM: gene MIM:602374 | disease phenotypes:

GWAS associations

3 associations:

StudyTraitp-value
GCST001840_3Stearic acid (18:0) levels2e-14
GCST001838_1Palmitic acid (16:0) levels3e-11
GCST008103_67Bipolar disorder1e-6

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (CPIC guideline: no)

CTD chemical–gene interactions

53 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects expression, decreases methylation, increases expression3
Cyclosporinedecreases expression3
Particulate Matterincreases methylation, decreases expression, increases abundance, affects cotreatment3
bisphenol Fincreases expression, affects cotreatment2
bisphenol Sincreases expression, affects cotreatment2
Cadmiumincreases abundance, increases palmitoylation, increases expression, decreases reaction2
Cadmium Chloridedecreases reaction, increases abundance, increases palmitoylation, increases expression2
trichostatin Adecreases expression1
sulforaphanedecreases expression1
sodium arseniteincreases expression1
2-bromopalmitatedecreases reaction, increases abundance, increases palmitoylation1
perfluorooctanoic aciddecreases expression1
cupric oxideincreases expression1
perfluorooctane sulfonic aciddecreases expression1
4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamideincreases expression1
candoxinincreases expression1
bisphenol Bincreases expression1
pentabrominated diphenyl ether 100decreases expression1
hexabrominated diphenyl ether 153decreases expression1
MRK 003decreases expression1
bisphenol AFincreases expression1
Temozolomideincreases expression1
Sunitinibdecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Ethanoldecreases expression1
Antimycin Aincreases expression1
Benzo(a)pyrenedecreases methylation1
Caffeineincreases phosphorylation1
Carbamazepineaffects expression1
Cisplatindecreases expression, decreases reaction1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_C8FJHAP1 CNN3 (-)Cancer cell lineMale

Clinical trials (associated diseases)

Via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.